Facebook
Twitter
LinkedIn
Forward
20th Annual International Ultmann Chicago Lymphoma Symposium
Chicago, IL US
April 21, 2023 to April 22, 2023
The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting will be a 2-day live meeting to discuss recent updates in the care of patients with solid and hematologic malignancies.
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting will be a 2-day live meeting to discuss recent updates in the care of patients with solid and hematologic malignancies.
Learn more at the symposium website! 
Target Audience
This activity is designed for practicing oncologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists, and other healthcare professionals interested in the treatment and diagnosis of lymphoma.
Learning Objectives
At the conclusion of this educational activity, participants will be able to:
- Debate the selection and sequencing of the latest advances to the treatment of patients with indolent and aggressive forms of non-Hodgkin lymphoma;
- Assess the safety and efficacy of current and emerging therapeutic approaches for the care of patients with Hodgkin lymphoma;
- Evaluate clinical trial data of current and emerging cellular therapy/CAR T-cell approaches for patients with lymphoma, including important safety and efficacy data;
- Review specific patient and disease-related factors that may impact therapeutic decisions for patients with newly diagnosed and previously treated CLL;
- Acquire strategies to communicate with and utilize the entire multidisciplinary team during the continuum of care of patients with lymphoma.
Agenda is subject to change.
Westin River North
320 N Dearborn St
Chicago, IL
60654
United States
WANT TO KNOW MORE?
Learn more about the program by visiting the symposium website!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via e-mail at iucls@bioascend.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
SYMPOSIUM CO-CHAIRS
Sonali M. Smith, MDElwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Director, Lymphoma Program
The University of Chicago
Andrew M. Evens, DO, MBA, MScProfessor of Medicine, Rutgers Robert Wood Johnson Medical School
Associate Director for Clinical Services, Rutger Cancer Institute of New Jersey
Director, Lymphoma Program, Division of Blood Disorders
Medical Director, Oncology Service Line, RWJBarnabas Health
Medical Director, Oncology Service Line, RWJBarnabas Health
Medical College of Wisconsin
Milwaukee, Wisconsin
Milwaukee, Wisconsin
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
University of Chicago Medicine is accredited as a provider of continuing nursing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Participants who successfully complete the entire activity and complete an evaluation form will earn 14.5 contact hours.
Participants who successfully complete the entire activity and complete an evaluation form will earn 14.5 contact hours.
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
REGISTRATION
Preview conference fees below then click the button to register! Early bird rates expire March 21, 2023!
Onsite Registration Available!
Proof of COVID-19 vaccination status is not required to register or attend the conference. However, we strongly recommend staying up to date with CDC vaccine recommendations. To ensure the safety of all attendees, and because of ongoing health risks, particularly to the unvaccinated, participants are expected to adopt the risk mitigation measures (masking and social distancing, etc.) appropriate to their vaccination status as advised by public health officials or to their individual vulnerabilities as advised by a medical professional. Public convening may not be safe for all and carries a risk for contracting COVID-19, particularly for those unvaccinated. Participants will not know the vaccination status of others and should follow appropriate risk mitigation measures.
For questions or concerns, please contact iucls@bioascend.com.
Symposium and InterprofessionalSession
| Profession Type | Early Bird Fee | After Early Bird Fee |
|---|---|---|
| Physician/PharmD/PhD | $325 | $375 |
| Nurse/OHP | $150 | $175 |
| Fellow/Resident/Student | $125 | $150 |
| Industry | $600 | $750 |
Symposium ONLY
| Profession Type | Early Bird Fee | After Early Bird Fee |
|---|---|---|
| Physician/PharmD/PhD | $275 | $325 |
| Nurse/OHP | $125 | $150 |
| Fellow/Resident/Student | $100 | $125 |
| Industry | $450 | $500 |
Nursing Session ONLY
| Profession Type | Early Bird Fee | After Early Bird Fee | |
|---|---|---|---|
| Physician/PharmD/PhD | $100 | $150 | |
| Nurse/OHP | $75 | $100 | |
| Fellow/Resident/Student | $75 | $100 | |
| Industry | $150 | $200 | |
CANCELLATION POLICY: See website for complete information. | |||
CLAIMING CREDIT
After the conference, create an account or log in and enter the access code to unlock the credit claiming process.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
Please login or create an account to proceed.